Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer

Published:2017-10 Issue: Volume:264 Page:276-287
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Soni Kruti S.,Lei Fan,Desale Swapnil S.,Marky Luis A.,Cohen Samuel M.,Bronich Tatiana K.

Funder

National Institute of General Medical Sciences

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Optimizing combination chemotherapy by controlling drug ratios;Mayer;Mol. Interv.,2007

2. Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effect;Hendriks;Mol. Cancer Ther.,2013

3. Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity;Inoue;Cancer Res.,2011

4. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer;Tolaney;N. Engl. J. Med.,2015

5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N. Engl. J. Med.,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors;Biomedicine & Pharmacotherapy;2024-01

2. Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer;Journal of Controlled Release;2023-08

3. Synthesis and Evaluation of a Paclitaxel-Binding Tripeptide Micelle for Lung Cancer Therapy;Chemical and Pharmaceutical Bulletin;2022-11-01

4. Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer;Journal of Controlled Release;2021-02

5. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer;Journal of Nanobiotechnology;2020-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3